|
| Status |
Public on Jun 12, 2024 |
| Title |
Capmatinib shows superior efficacy for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy. |
| Organisms |
Homo sapiens; Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Methylation profiling by genome tiling array
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
38849845 |
| |
| Submission date |
Jan 03, 2024 |
| Last update date |
Jun 13, 2024 |
| Contact name |
Jared Andrews |
| E-mail(s) |
jared.andrews@stjude.org
|
| Organization name |
St. Jude Children's Research Hospital
|
| Department |
Developmental Neurobiology
|
| Street address |
262 Danny Thomas Pl
|
| City |
Memphis |
| State/province |
Tennessee |
| ZIP/Postal code |
38105 |
| Country |
USA |
| |
|
| Platforms (3) |
| GPL21145 |
Infinium MethylationEPIC |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
| GPL32685 |
Illumina Infinium MouseMethylation array (MouseMethylation-12v1-0_A2) |
|
| Samples (48)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE247864 |
Capmatinib shows superior efficacy for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy [RNA-seq] |
| GSE252458 |
Capmatinib shows superior efficacy for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy [human methylation array] |
| GSE252500 |
Capmatinib shows superior efficacy for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy (mouse methylation array) |
|
| Relations |
| BioProject |
PRJNA1060685 |
Less...
More...